A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes

Cancer Immunology, Immunotherapy

Volumn 58, Issue 4, 2009, Pages 553-566

  Bouquié, Régis ^a   Bonnin, Annabelle ^a   Bernardeau, Karine ^a   Khammari, Amir ^b   Dréno, Brigitte ^a,b   Jotereau, Francine ^a,c   Labarrière, Nathalie ^a   Lang, François ^a,c  

^a Team 12   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

Cell sorting; HLA multimers; Immunotherapy; Melanoma; T lymphocytes

Indexed keywords

ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; GLYCOPROTEIN GP 100; HLA ANTIBODY; HLA ANTIGEN; HLA MULTIMER; MELAN A; MELANOMA ANTIGEN; POLYMER; REAGENT; SIGNAL PEPTIDE; STREPTAVIDIN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL LINE; CELL TRANSFER; CROSS LINKING; CYTOKINE PRODUCTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MELANOMA; MELANOMA CELL; MULTIMETHOD STUDY; NEOPLASM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, NEOPLASM; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; IMMUNOMAGNETIC SEPARATION; MELANOMA; SURFACE PLASMON RESONANCE;

EID: 59449102958     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0578-2     Document Type: Article

References (31)

1. CM Rooney CA Smith CY Ng SK Loftin JW Sixbey Y Gan DK Srivastava LC Bowman RA Krance MK Brenner HE Heslop 1998 Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1549 1555
2. A Gustafsson V Levitsky JZ Zou T Frisan T Dalianis P Ljungman O Ringden J Winiarski I Ernberg MG Masucci 2000 Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells Blood 95 807 814
3. B Savoldo JA Goss MM Hammer L Zhang T Lopez AP Gee YF Lin RE Quiros-Tejeira P Reinke S Schubert S Gottschalk MJ Finegold MK Brenner CM Rooney HE Heslop 2006 Treatment of solid organ transplant recipients with autologous Epstein-Barr virus-specific cytotoxic T lymphocytes (CTLs) Blood 108 2942 2949
4. HJ Kolb J Mittermuller C Clemm E Holler G Ledderose G Brehm M Heim W Wilmanns 1990 Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 2462 2465
5. B Dreno JM Nguyen A Khammari MC Pandolfino MH Tessier S Bercegeay A Cassidanius P Lemarre S Billaudel N Labarriere F Jotereau 2002 Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma Cancer Immunol Immunother 51 539 546
6. ME Dudley JR Wunderlich PF Robbins JC Yang P Hwu DJ Schwartzentruber SL Topalian R Sherry NP Restifo AM Hubicki MR Robinson M Raffeld P Duray CA Seipp L Rogers-Freezer KE Morton SA Mavroukakis DE White SA Rosenberg 2002 Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 850 854
7. N Labarriere MC Pandolfino N Gervois A Khammari MH Tessier B Dreno F Jotereau 2002 Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients Cancer Immunol Immunother 51 532 538
8. P Guillaume DF Legler N Boucheron MA Doucey JC Cerottini IF Luescher 2003 Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis J Biol Chem 278 4500 4509
9. M Cebecauer P Guillaume P Hozak S Mark H Everett P Schneider IF Luescher 2005 Soluble MHC-peptide complexes induce rapid death of CD8 + CTL J Immunol 174 6809 6819
10. M Cobbold N Khan B Pourgheysari S Tauro D McDonald H Osman M Assenmacher L Billingham C Steward C Crawley E Olavarria J Goldman R Chakraverty P Mahendra C Craddock PA Moss 2005 Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers J Exp Med 202 379 386
11. M Bodinier MA Peyrat C Tournay F Davodeau F Romagne M Bonneville F Lang 2000 Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding Nat Med 6 707 710
12. N Labarriere N Gervois A Bonnin R Bouquie F Jotereau F Lang 2008 PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting Cancer Immunol Immunother 57 185 195
13. N Gervois F Heuze E Diez F Jotereau 1990 Selective expansion of a specific anti-tumor CD8 + cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements Eur J Immunol 20 825 831
14. F Jotereau MC Pandolfino D Boudart E Diez B Dreno JY Douillard JY Muller 1991 LeMevel B (1991) High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy J Immunother 10 405 411
15. D Valmori JF Fonteneau CM Lizana N Gervois D Lienard D Rimoldi V Jongeneel F Jotereau JC Cerottini P Romero 1998 Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues J Immunol 160 1750 1758
16. AL Cox J Skipper Y Chen RA Henderson TL Darrow J Shabanowitz VH Engelhard DF Hunt CL Slingluff Jr 1994 Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines Science 264 716 719
17. Y Guilloux S Lucas VG Brichard A Van Pel C Viret E De Plaen F Brasseur B Lethe F Jotereau T Boon 1996 A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene J Exp Med 183 1173 1183
18. V Vignard B Lemercier A Lim MC Pandolfino Y Guilloux A Khammari C Rabu K Echasserieau F Lang ML Gougeon B Dreno F Jotereau N Labarriere 2005 Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells J Immunol 175 4797 4805
19. N Gervois N Labarriere S Le Guiner MC Pandolfino JF Fonteneau Y Guilloux E Diez B Dreno F Jotereau 2000 High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells Clin Cancer Res 6 1459 1467
20. DJ Cole MC Wilson L Rivoltini M Custer MI Nishimura 1997 T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes Cancer Res 57 5320 5327
21. A Mackensen N Meidenbauer S Vogl M Laumer J Berger R Andreesen 2006 Phase I study of adoptive T-cell therapy using antigen-specific CD8 + T cells for the treatment of patients with metastatic melanoma J Clin Oncol 24 5060 5069
22. N Labarriere L Bretaudeau N Gervois M Bodinier G Bougras E Diez F Lang M Gregoire F Jotereau 2002 Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen Int J Cancer 101 280 286
23. S Yang GP Linette S Longerich FG Haluska 2002 Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2 M is correlated to TCR avidity J Immunol 169 531 539
24. M Cebecauer P Guillaume S Mark O Michielin N Boucheron M Bezard BH Meyer JM Segura H Vogel IF Luescher 2005 CD8 + cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimers J Biol Chem 280 23820 23828
25. S Freitag I Le Trong L Klumb PS Stayton RE Stenkamp 1997 Structural studies of the streptavidin binding loop Protein Sci 6 1157 1166
26. V Dutoit V Rubio-Godoy PY Dietrich AL Quiqueres V Schnuriger D Rimoldi D Lienard D Speiser P Guillaume P Batard JC Cerottini P Romero D Valmori 2001 Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity Cancer Res 61 5850 5856
27. EM Creagh H Conroy SJ Martin 2003 Caspase-activation pathways in apoptosis and immunity Immunol Rev 193 10 21
28. ME Peter PH Krammer 2003 The CD95(APO-1/Fas) DISC and beyond Cell Death Differ 10 26 35
29. K Gulow M Kaminski K Darvas D Suss M Li-Weber PH Krammer 2005 HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death J Immunol 174 5249 5260
30. M Knabel TJ Franz M Schiemann A Wulf B Villmow B Schmidt H Bernhard H Wagner DH Busch 2002 Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer Nat Med 8 631 637
31. J Neudorfer B Schmidt KM Huster F Anderl M Schiemann G Holzapfel T Schmidt L Germeroth H Wagner C Peschel DH Busch H Bernhard 2007 Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens J Immunol Meth 320 119 131